Amalia Ruiz

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Molecularly Imprinted

Prostate Cancer

Top Venues

International journal of molecular sciences

RSC pharmaceutics

Nanoscale advances

This page only lists publications with an associated author ORCID identifier.

Publications

Abdullahi Magaji Dauda, Thomas Swift, Richard Telford, Hend A A Abd El-Wahab, Chhanda Charan Danta, Klaus Pors, Amalia Ruiz
Insight into the liposomal encapsulation of mono and bis-naphthalimides. RSC pharmaceutics 1 (2) (2024)
Abdullahi Magaji Dauda, Thomas Swift, Richard Telford, Hend A A Abd El-Wahab, Chhanda Charan Danta, Klaus Pors, Amalia Ruiz
Insight into the liposomal encapsulation of mono and bis-naphthalimides. RSC pharmaceutics 1 (2) (2024)
Chandrima Das, Cristina Martín, Sebastian Habermann, Harriet Rose Walker, Javed Iqbal, Jacobo Elies Gomez, Huw Simon Jones, Giacomo Reina, Amalia Ruiz
Co-Loading of Black Phosphorus Nanoflakes and Doxorubicin in Lysolipid Temperature-Sensitive Liposomes for Combination Therapy in Prostate Cancer. International journal of molecular sciences 25 (1) (2023)
Chandrima Das, Cristina Martín, Sebastian Habermann, Harriet Rose Walker, Javed Iqbal, Jacobo Elies Gomez, Huw Simon Jones, Giacomo Reina, Amalia Ruiz
Co-Loading of Black Phosphorus Nanoflakes and Doxorubicin in Lysolipid Temperature-Sensitive Liposomes for Combination Therapy in Prostate Cancer. International journal of molecular sciences 25 (1) (2023)
Chandrima Das, Cristina Martín, Sebastian Habermann, Harriet Rose Walker, Javed Iqbal, Jacobo Elies Gomez, Huw Simon Jones, Giacomo Reina, Amalia Ruiz
Co-Loading of Black Phosphorus Nanoflakes and Doxorubicin in Lysolipid Temperature-Sensitive Liposomes for Combination Therapy in Prostate Cancer. International journal of molecular sciences 25 (1) (2023)
Amalia Ruiz, Cristina Martín, Giacomo Reina
Does black phosphorus hold potential to overcome graphene oxide? A comparative review of their promising application for cancer therapy. Nanoscale advances 3 (14) (2021)